Gadolinium oxide: a protoype agent for contrast enhanced imaging of the liver and spleen with magnetic resonance.
Gd2O3 particles (less than 2 microns) in suspension were evaluated as a potential contrast agent for liver-spleen imaging with magnetic resonance. The agent was administered IV to rabbits in doses ranging from 10 to 120 mumol/kg and the tissues removed after sacrifice for in vitro T1 and T2 analysis. The temporal response was determined in liver and spleen samples of rabbits given a fixed dose (60 mumol/kg) and sacrificed at intervals from 15 min to 60 hr later. Documentation of the subanatomic location of Gd2O3 particles in tissue was accomplished by electron microscopy and x-ray dispersion microanalysis. T1 weighted images were obtained at 0.12T on a prototype resistive scanner. The liver, spleen, and lung relaxation times are very responsive to Gd2O3 IV and the effect is dose related. A peak effect is observed between 3-7 hr after injection and relaxation times may normalize by 60 hr. By electron microscopic and x-ray analysis, Gd2O3 is most prominently found in the hepatic and splenic sinusoids. The images show marked enhancement of liver and splenic tissues, aiding in the clear delineation of these tissues from neighboring structures.
D000818:Animals; D003287:Contrast Media; D005682:Gadolinium / Q000378:metabolism; D008099:Liver / Q000033:anatomy & histology*; D009682:Magnetic Resonance Spectroscopy; D011817:Rabbits; D013154:Spleen / Q000033:anatomy & histology*; D014018:Tissue Distribution
D003287:Contrast Media; C030581:gadolinium oxide; D005682:Gadolinium